SG11202007328UA - Pyrazole compounds and preparation thereof - Google Patents
Pyrazole compounds and preparation thereofInfo
- Publication number
- SG11202007328UA SG11202007328UA SG11202007328UA SG11202007328UA SG11202007328UA SG 11202007328U A SG11202007328U A SG 11202007328UA SG 11202007328U A SG11202007328U A SG 11202007328UA SG 11202007328U A SG11202007328U A SG 11202007328UA SG 11202007328U A SG11202007328U A SG 11202007328UA
- Authority
- SG
- Singapore
- Prior art keywords
- preparation
- pyrazole compounds
- pyrazole
- compounds
- Prior art date
Links
- 150000003217 pyrazoles Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/70—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
- B01J23/72—Copper
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
- B01J27/06—Halogens; Compounds thereof
- B01J27/08—Halides
- B01J27/122—Halides of copper
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Materials Engineering (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201811003855 | 2018-02-01 | ||
IN201811003859 | 2018-02-01 | ||
IN201711042921 | 2018-05-30 | ||
PCT/IN2019/050076 WO2019150392A1 (en) | 2018-02-01 | 2019-02-01 | Pyrazole compounds and preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202007328UA true SG11202007328UA (en) | 2020-08-28 |
Family
ID=67478207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202007328UA SG11202007328UA (en) | 2018-02-01 | 2019-02-01 | Pyrazole compounds and preparation thereof |
Country Status (13)
Country | Link |
---|---|
US (1) | US11873289B2 (ja) |
EP (1) | EP3746434A4 (ja) |
JP (1) | JP7402804B2 (ja) |
KR (1) | KR20200118025A (ja) |
CN (1) | CN111670184A (ja) |
AU (1) | AU2019213854C1 (ja) |
BR (1) | BR112020015692A2 (ja) |
CA (1) | CA3090204A1 (ja) |
IL (1) | IL276410B1 (ja) |
MA (1) | MA54677A (ja) |
MX (1) | MX2020008151A (ja) |
SG (1) | SG11202007328UA (ja) |
WO (1) | WO2019150392A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200118025A (ko) | 2018-02-01 | 2020-10-14 | 미요카디아, 인크. | 피라졸 화합물 및 그의 제조 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007284386A (ja) | 2006-04-18 | 2007-11-01 | Kumiai Chem Ind Co Ltd | 3−ピラゾリルフェニルスルフィド誘導体及びそれを有効成分として含有する殺虫・殺ダニ・殺線虫剤 |
US8324178B2 (en) * | 2008-10-31 | 2012-12-04 | The Regents Of The University Of California | Method of treatment using alpha-1-adrenergic agonist compounds |
US9260416B2 (en) * | 2011-05-27 | 2016-02-16 | Amira Pharmaceuticals, Inc. | Heterocyclic autotaxin inhibitors and uses thereof |
BR112015004097B1 (pt) | 2012-08-30 | 2020-02-18 | Bayer Cropscience Ag | Procedimento para a descarboxilação de derivados do ácido 3,5-bis (haloalquil) -pirazol-4-carboxílico |
CN104968664A (zh) | 2012-12-12 | 2015-10-07 | 山东亨利医药科技有限责任公司 | 作为酪氨酸激酶抑制剂的并环化合物 |
JP6446464B2 (ja) | 2013-11-01 | 2018-12-26 | エスアールエフ リミテッド | ピラゾール誘導体の製造方法 |
EP3015458A1 (en) | 2014-11-03 | 2016-05-04 | Bayer CropScience AG | Process for preparing 3,5-bis(haloalkyl)pyrazole derivatives from a,a-dihaloamines and ketimines |
EA036923B1 (ru) | 2015-01-22 | 2021-01-15 | Миокардиа, Инк. | Соединения 4-метилсульфонилзамещенной пиперидинмочевины для лечения дилатационной кардиомиопатии (dcm) |
EP3568390B1 (en) * | 2017-01-10 | 2024-03-06 | Sanford Burnham Prebys Medical Discovery Institute | Small molecule activators of nicotinamide phosphoribosyltransferase (nampt) and uses thereof |
CA3059428A1 (en) | 2017-04-11 | 2018-10-18 | Oric Pharmaceuticals, Inc. | Glucocorticoid receptor modulators |
KR20200118025A (ko) | 2018-02-01 | 2020-10-14 | 미요카디아, 인크. | 피라졸 화합물 및 그의 제조 |
-
2019
- 2019-02-01 KR KR1020207022279A patent/KR20200118025A/ko unknown
- 2019-02-01 MA MA054677A patent/MA54677A/fr unknown
- 2019-02-01 CA CA3090204A patent/CA3090204A1/en active Pending
- 2019-02-01 SG SG11202007328UA patent/SG11202007328UA/en unknown
- 2019-02-01 JP JP2020541983A patent/JP7402804B2/ja active Active
- 2019-02-01 US US16/966,502 patent/US11873289B2/en active Active
- 2019-02-01 MX MX2020008151A patent/MX2020008151A/es unknown
- 2019-02-01 BR BR112020015692-2A patent/BR112020015692A2/pt unknown
- 2019-02-01 CN CN201980011350.9A patent/CN111670184A/zh active Pending
- 2019-02-01 WO PCT/IN2019/050076 patent/WO2019150392A1/en active Application Filing
- 2019-02-01 IL IL276410A patent/IL276410B1/en unknown
- 2019-02-01 AU AU2019213854A patent/AU2019213854C1/en active Active
- 2019-02-01 EP EP19747117.0A patent/EP3746434A4/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2019213854A1 (en) | 2020-09-03 |
IL276410A (en) | 2020-09-30 |
BR112020015692A2 (pt) | 2020-12-08 |
US11873289B2 (en) | 2024-01-16 |
AU2019213854B2 (en) | 2023-06-15 |
US20210053940A1 (en) | 2021-02-25 |
KR20200118025A (ko) | 2020-10-14 |
EP3746434A1 (en) | 2020-12-09 |
WO2019150392A1 (en) | 2019-08-08 |
MX2020008151A (es) | 2020-09-18 |
CA3090204A1 (en) | 2019-08-08 |
EP3746434A4 (en) | 2021-11-17 |
JP2021512127A (ja) | 2021-05-13 |
JP7402804B2 (ja) | 2023-12-21 |
IL276410B1 (en) | 2024-05-01 |
MA54677A (fr) | 2021-11-17 |
AU2019213854C1 (en) | 2023-12-14 |
CN111670184A (zh) | 2020-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL282617A (en) | Aerosol formulation | |
GB201801614D0 (en) | Formulation | |
IL282523A (en) | Aerosol formulation | |
IL277686A (en) | Heteroaryl-substituted pyrazole compounds and their pharmaceutical use | |
IL282589A (en) | Aerosol formulation | |
IL282567A (en) | Aerosol formulation | |
IL277502A (en) | Compounds and uses for them | |
HUE060805T2 (hu) | Piridinamin-piridon és pirimidinamin-piridon vegyületek | |
IL282461A (en) | Aerosol formulation | |
IL279483A (en) | Cyanotriazole compounds and their uses | |
IL280644A (en) | Magnesium serine compound and its use | |
IL282697A (en) | Aerosol formulation | |
IL282392A (en) | Aerosol formulation | |
EP3681877A4 (en) | PYRAZOLE DERIVATIVE COMPOUND AND USE THEREOF | |
IL277749A (en) | Palladianolide compounds and their use | |
GB201816447D0 (en) | Formulation | |
GB201813370D0 (en) | Binder formulation | |
IL276410A (en) | Pyrazole compounds and their preparation | |
GB201807312D0 (en) | Formulation | |
GB201801102D0 (en) | New compounds and uses | |
GB201700404D0 (en) | Compounds and composistions | |
IL280138A (en) | Spray formulation | |
GB201813229D0 (en) | Formulation | |
HUE057818T2 (hu) | Azaindolilpiridon és diazaindolilpiridon vegyületek | |
GB201806349D0 (en) | New compounds and uses |